Your browser doesn't support javascript.
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity.
Mehta, Puja; Rosas, Ivan O; Singer, Mervyn.
  • Mehta P; Centre for Inflammation and Tissue Repair, Division of Medicine, UCL Respiratory, University College London (UCL), Rayne 9 Building, London, WC1E 6JF, UK. puja.mehta@ucl.ac.uk.
  • Rosas IO; Department of Rheumatology, University College London Hospital (UCLH), London, UK. puja.mehta@ucl.ac.uk.
  • Singer M; Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.
Intensive Care Med ; 48(12): 1803-1806, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2007126
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Diseases, Interstitial / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06877-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Diseases, Interstitial / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06877-w